|
Feb 20
|
EPKINLY® (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare for Additional Indication as a Treatment for Relapsed or Refractory Follicular Lymphoma
|
|
Feb 19
|
Genmab to Participate in a Fireside Chat at the 45th Annual TD Cowen Health Care Conference
|
|
Jan 3
|
Genmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|